The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal (Q48274036)

10 February 2018

title

The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal (English)

1 reference

10 February 2018

1 reference

Kelly H Skelton

1

1 reference

10 February 2018

David A Gutman

2

1 reference

10 February 2018

K V Thrivikraman

3

1 reference

10 February 2018

Charles B Nemeroff

4

1 reference

10 February 2018

Michael J Owens

5

1 reference

10 February 2018

publication date

13 February 2007

1 reference

10 February 2018

number of pages

12

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

10 February 2018

volume

192

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

385-396

1 reference

10 February 2018

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0713-3

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

12 December 2020

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal

1 reference

12 December 2020

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain

1 reference

12 December 2020

Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN)

1 reference

12 December 2020

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone

1 reference

12 December 2020

Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal

1 reference

12 December 2020

Physiology and pharmacology of corticotropin-releasing factor

1 reference

12 December 2020

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety

1 reference

12 December 2020

Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala

1 reference

12 December 2020

Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.

1 reference

12 December 2020

Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine

1 reference

12 December 2020

Role of corticotropin-releasing factor receptor-1 in opiate withdrawal

1 reference

12 December 2020

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis

1 reference

12 December 2020

Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response

1 reference

12 December 2020

The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal

1 reference

12 December 2020

Effect of chlordiazepoxide on stress in rats

1 reference

12 December 2020

Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function

1 reference

12 December 2020

Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats

1 reference

12 December 2020

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

12 December 2020

Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.

1 reference

12 December 2020

ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats

1 reference

12 December 2020

Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats

1 reference

12 December 2020

Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment

1 reference

12 December 2020

Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated

1 reference

12 December 2020

Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system

1 reference

12 December 2020

In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications

1 reference

12 December 2020

Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal

1 reference

12 December 2020

Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder

1 reference

12 December 2020

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

1 reference

12 December 2020

Experimental induction of benzodiazepine tolerance and physical dependence

1 reference

12 December 2020

Corticotropin-releasing factor has an anxiogenic action in the social interaction test

1 reference

12 December 2020

Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment.

1 reference

12 December 2020

Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test

1 reference

12 December 2020

The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress

1 reference

12 December 2020

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

1 reference

12 December 2020

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence

1 reference

12 December 2020

Long-term pharmacologic treatment of panic disorder

1 reference

12 December 2020

Ethanol dependence and the pituitary adrenal axis in mice. II. Temporal analysis of dependence and withdrawal

1 reference

12 December 2020

The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam

1 reference

12 December 2020

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

1 reference

12 December 2020

Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus

1 reference

12 December 2020

Characteristics of long-term alprazolam users in the community

1 reference

12 December 2020

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

12 December 2020

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

12 December 2020

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

12 December 2020

Sensitivity to glucocorticoid-mediated fast-feedback regulation of the hypothalamic-pituitary-adrenal axis is dependent upon stressor specific neurocircuitry

1 reference

12 December 2020

Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.

1 reference

12 December 2020

Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal

1 reference

12 December 2020

Jugular vein catheterization for repeated blood sampling in the unrestrained conscious rat.

1 reference

12 December 2020

Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepoxide withdrawal is not due to enhanced noradrenergic activity

1 reference

12 December 2020

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

1 reference

12 December 2020

Combined pre- and postnatal environmental enrichment programs the HPA axis differentially in male and female rats

1 reference

12 December 2020

10.1007/S00213-007-0713-3

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018